[CH2:1]([N:3]1[C:12]2[C:7](=[CH:8][C:9]([F:14])=[C:10](F)[CH:11]=2)[C:6](=[O:15])[C:5]([C:16]([OH:18])=[O:17])=[CH:4]1)[CH3:2].[CH:19]1([CH:22]2[NH:27][CH2:26][CH2:25][NH:24][CH2:23]2)[CH2:21][CH2:20]1>N1C=CC=CC=1>[CH:19]1([CH:22]2[NH:27][CH2:26][CH2:25][N:24]([C:10]3[CH:11]=[C:12]4[C:7]([C:6](=[O:15])[C:5]([C:16]([OH:18])=[O:17])=[CH:4][N:3]4[CH2:1][CH3:2])=[CH:8][C:9]=3[F:14])[CH2:23]2)[CH2:21][CH2:20]1A mixture of 1.265 g of 1-ethyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1.86 g of 3-cyclopropylpiperazine and 15 ml of pyridine was heated at 100° C. in a pressure bottle for 3 hours, then cooled and evaporated. The residue was purified by silica gel flash chromatography, eluting with chloroform:methanol:water:triethylamine (9:0.5:0.02:0.02), giving 180 mg of the desired product, mp 250° C. (dec.).